Healthcare provider profile · identity verified

David H Jarosz, ARNP

Nurse Practitioner · KEYSTONE HEIGHTS, FL · NPI 1225003460

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	477	161
Amlodipine Besylate	Amlodipine Besylate	460	148
Lisinopril	Lisinopril	347	124
Gabapentin	Gabapentin	317	88
Albuterol Sulfate Hfa	Albuterol Sulfate	290	74
Omeprazole	Omeprazole	249	80
Levothyroxine Sodium	Levothyroxine Sodium	227	74
Tramadol Hcl	Tramadol Hcl	206	36
Metformin Hcl	Metformin Hcl	197	75
Trazodone Hcl	Trazodone Hcl	185	51
Losartan Potassium	Losartan Potassium	159	53
Rosuvastatin Calcium	Rosuvastatin Calcium	145	59
Metoprolol Succinate	Metoprolol Succinate	141	48
Tamsulosin Hcl	Tamsulosin Hcl	126	43
Furosemide	Furosemide	125	48
Hydrochlorothiazide	Hydrochlorothiazide	123	38
Metoprolol Tartrate	Metoprolol Tartrate	123	38
Sertraline Hcl	Sertraline Hcl	118	41
Pantoprazole Sodium	Pantoprazole Sodium	110	38
Prednisone	Prednisone	108	69
Clopidogrel	Clopidogrel Bisulfate	107	31
Eliquis	Apixaban	94	26
Fluticasone Propionate	Fluticasone Propionate	91	33
Baclofen	Baclofen	85	27
Tizanidine Hcl	Tizanidine Hcl	82	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	81	18
Alprazolam	Alprazolam	80	17
Pregabalin	Pregabalin	76	17
Simvastatin	Simvastatin	76	24
Symbicort	Budesonide/Formoterol Fumarate	76	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	75	24
Carvedilol	Carvedilol	74	24
Clonazepam	Clonazepam	74	16
Duloxetine Hcl	Duloxetine Hcl	74	25
Citalopram Hbr	Citalopram Hydrobromide	73	21
Hydroxyzine Hcl	Hydroxyzine Hcl	71	19
Ventolin Hfa	Albuterol Sulfate	70	23
Lorazepam	Lorazepam	69	14
Meloxicam	Meloxicam	69	21
Bupropion Xl	Bupropion Hcl	65	14
Montelukast Sodium	Montelukast Sodium	60	17
Zolpidem Tartrate	Zolpidem Tartrate	59	15
Metformin Hcl Er	Metformin Hcl	58	18
Allopurinol	Allopurinol	57	19
Pravastatin Sodium	Pravastatin Sodium	56	17
Diclofenac Sodium	Diclofenac Sodium	55	12
Glipizide	Glipizide	55	21
Temazepam	Temazepam	51	suppressed
Spironolactone	Spironolactone	47	11
Famotidine	Famotidine	46	12
Dicyclomine Hcl	Dicyclomine Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	11
Venlafaxine Hcl Er	Venlafaxine Hcl	44	14
Buspirone Hcl	Buspirone Hcl	43	suppressed
Jardiance	Empagliflozin	43	12
Fluoxetine Hcl	Fluoxetine Hcl	41	11
Pioglitazone Hcl	Pioglitazone Hcl	41	14
Potassium Chloride	Potassium Chloride	41	15
Xarelto	Rivaroxaban	40	suppressed
Aripiprazole	Aripiprazole	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	16
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	12
Triamcinolone Acetonide	Triamcinolone Acetonide	39	25
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Glimepiride	Glimepiride	37	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	28
Azithromycin	Azithromycin	36	34
Atenolol	Atenolol	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	12
Tresiba Flextouch U-100	Insulin Degludec	34	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Meclizine Hcl	Meclizine Hcl	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Amitriptyline Hcl	Amitriptyline Hcl	29	11
Cephalexin	Cephalexin	29	25
Glipizide Er	Glipizide	29	11
Warfarin Sodium	Warfarin Sodium	29	suppressed
Naproxen	Naproxen	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Estradiol	Estradiol	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Risperidone	Risperidone	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Lantus	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	14
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Levemir	Insulin Detemir	20	suppressed
Ozempic	Semaglutide	20	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Atrovent Hfa	Ipratropium Bromide	19	suppressed
Entresto	Sacubitril/Valsartan	19	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Finasteride	Finasteride	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Novolin N	Insulin Nph Human Isophane	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Amoxicillin	Amoxicillin	15	13
Clonidine Hcl	Clonidine Hcl	15	suppressed
Lactulose	Lactulose	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Trulicity	Dulaglutide	15	suppressed
Diazepam	Diazepam	14	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	14	12
Donepezil Hcl	Donepezil Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	12	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Vraylar	Cariprazine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error